EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease

Moira S Lewitt, Gary W Boyd iD

Biomolecules · 20.11.2024 · 14 (11) · 1475

DOI: 10.3390/biom14111475 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 20.11.2024. Verfasst von Moira S Lewitt und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Life Sciences, University of the West of Scotland, Paisley PA1 2BE, UK. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor Binding Protein 1, Biomarkers, Cardiovascular Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin-like growth factor-binding protein-1 (IGFBP-1) contributes to the regulation of IGFs for metabolism and growth and has IGF-independent actions. IGFBP-1 in the circulation is derived from the liver, where it is inhibited by insulin and stimulated by multiple factors, including proinflammatory cytokines. IGFBP-1 levels are influenced by sex and age, which also determine cardiometabolic risk and patterns of disease presentation. While lower circulating IGFBP-1 concentrations are associated with an unfavorable cardiometabolic risk profile, higher IGFBP-1 predicts worse cardiovascular disease outcomes. This review explores these associations and the possible roles of IGFBP-1 in the pathophysiology of atherosclerosis. We recommend the evaluation of dynamic approaches, such as simultaneous measurements of fasting IGFBP-1 and proinsulin level in response to an oral glucose challenge, as well as multi-marker approaches incorporating markers of inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor Binding Protein 1BiomarkersCardiovascular DiseasesHumansAtherosclerosisInsulin-Like Peptides

Stichwörter der Autor:innen

IGF-binding protein-1/IGFBP-1cardiometabolic riskinsulin resistanceinsulin-like growth factor/IGF

Substanzen

Insulin-Like Growth Factor Binding Protein 1BiomarkersIGFBP1 protein, humanInsulin-Like Peptides

Autor:innen und Institutionen

  • School of Health and Life Sciences, University of the West of Scotland, Paisley PA1 2BE, UK.
  • School of Health and Life Sciences, University of the West of Scotland, Hamilton G72 0LH, UK.

ORCID-Profile: Gary W Boyd

Zitieren

APA

Lewitt, M. S., & Boyd, G. W. (2024). Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease. Biomolecules, 14(11), 1475. https://doi.org/10.3390/biom14111475

Vancouver

Lewitt MS, Boyd GW. Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease. Biomolecules. 2024;14(11):1475. doi:10.3390/biom14111475

BibTeX
@article{Lewitt2024,
  author = {Lewitt, Moira S and Boyd, Gary W},
  title = {Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {11},
  pages = {1475},
  doi = {10.3390/biom14111475}
}
Kostenlos starten →